Filing Details
- Accession Number:
- 0001144204-16-089880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-23 17:27:02
- Reporting Period:
- 2016-03-23
- Filing Date:
- 2016-03-23
- Accepted Time:
- 2016-03-23 17:27:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | Pharmaceutical Preparations (2834) | 261434750 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563420 | Seth Lederman | C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2016-03-23 | 8,000 | $2.44 | 80,815 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.001 Par Value | 6,000 | Indirect | By spouse |
Common Stock, $0.001 Par Value | 29,167 | Indirect | By Leder Laboratories, Inc. |
Common Stock, $0.001 Par Value | 29,167 | Indirect | By Starling Pharmaceuticals, Inc. |
Common Stock, $0.001 Par Value | 184,628 | Indirect | By Lederman & Co., LLC |
Common Stock, $0.001 Par Value | 32,457 | Indirect | By L&L Technologies, LLC |
Common Stock, $0.001 Par Value | 58,972 | Indirect | By Targent Pharmaceuticals, LLC |
Footnotes
- The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.442145. The range of purchase prices on the transaction date was $2.40 to $2.48 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
- Reporting person may be deemed to be a control person of this entity.